⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of PRECISIS GmbH and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
PRECISIS GmbH
↗Heidelberg, Germany
PRECISIS GmbH is a Heidelberg-based medical technology company specializing in the development of innovative, minimally invasive bioelectronic therapies for neurological disorders. The company is best known for its EASEE® (Epicranial Application of Stimulation Electrodes for Epilepsy) system, a first-in-class neurostimulation technology designed to treat drug-resistant focal epilepsy without the need for invasive brain surgery.
Founded in 2004, the company focuses on bridging the gap between medication and traditional brain surgery. By utilizing epicranial electrodes placed beneath the scalp, PRECISIS offers a targeted, patient-centered approach to neuromodulation. The company is currently scaling its operations across Europe and expanding into the U.S. market following recent FDA IDE approval for its pivotal clinical study.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2004
Ownership:private
Status:operating
FUNDING
Stage:Venture Capital
Total Raised:$20M+
Investors:European Investment Bank (EIB)
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Europe), Phase 3/Pivotal (US)
Modalities:Neurostimulation, Bioelectronic medicine
Active Trials:1
Trial Phases:Phase 3: 1
FDA Approvals:0
EMA Approvals:1
CORPORATE STRUCTURE
Key Partnerships:Cochlear (Strategic Alliance established 2021)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Karl Stoklosa - CEO
Michael Tittelbach - CTO
Board Members:Dr. Felix Baader, Andrew Bishop, Dr. med. Angela Liedler, André Burch, Peter Weiland, Thorben Katzer
LINKS
Website:precisis.de
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with PRECISIS GmbH. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.